Instil Bio Inc
General ticker "TIL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $160.8M
Instil Bio Inc follows the US Stock Market performance with the rate: 34.8%.
Estimated limits based on current volatility of 3.9%: low 20.06$, high 21.71$
Factors to consider:
- Current price 85.6% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.78$, 11.79$]
- 2024-12-30 to 2025-12-30 estimated range: [3.28$, 10.00$]
Financial Metrics affecting the TIL estimates:
- Negative: Non-GAAP EPS, $ of -22.79 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -65.05 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Interest expense per share, $ of 0.80 > 0.74
Short-term TIL quotes
Long-term TIL plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $155.56MM | $226.46MM | $159.17MM |
Operating Income | $-155.56MM | $-226.46MM | $-159.17MM |
Non-Operating Income | $-1.20MM | $1.21MM | $3.08MM |
Interest Expense | $0.00MM | $1.88MM | $5.21MM |
R&D Expense | $107.25MM | $141.06MM | $39.60MM |
Income(Loss) | $-156.75MM | $-225.25MM | $-156.09MM |
Taxes | $0.04MM | $-2.07MM | $0.00MM |
Profit(Loss) | $-156.79MM | $-223.18MM | $-156.09MM |
Stockholders Equity | $555.20MM | $363.61MM | $225.83MM |
Assets | $609.98MM | $482.13MM | $325.63MM |
Operating Cash Flow | $-122.14MM | $-180.16MM | $-82.03MM |
Capital expenditure | $57.83MM | $84.59MM | $20.66MM |
Investing Cash Flow | $-474.40MM | $114.54MM | $41.13MM |
Financing Cash Flow | $393.16MM | $71.89MM | $8.08MM |
Earnings Per Share* | $-24.30 | $-34.46 | $-24.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.